Corrigendum: An in vivo fluorescence resonance energy transfer-based imaging platform for targeted drug discovery and cancer therapy

Front Bioeng Biotechnol. 2022 Sep 26:10:1039177. doi: 10.3389/fbioe.2022.1039177. eCollection 2022.

Fuqiang Xing^{1

2

3}, Nana Ai⁴, Shigao Huang¹, Cheng Jiang⁵, Muhammad Jameel Mughal¹, Wei Ge⁴, Guanyu Wang^{2

5}, Chu-Xia Deng¹

¹ Cancer Center, Faculty of Health Sciences, University of Macau, Macau SAR, China.
² Department of Biology, School of Life Sciences, Guangdong Provincial Key Laboratory of Computational Science and Material Design, Southern University of Science and Technology, Shenzhen, China.
³ Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, China.
⁴ Centre of Reproduction, Development and Aging, Faculty of Health Sciences, University of Macau, Macau SAR, China.
⁵ School of Life and Health Sciences, The Chinese University of Hong Kong, Shenzhen, China.

Abstract

[This corrects the article DOI: 10.3389/fbioe.2022.839078.].

Keywords: FRET technique; apoptosis; cancer therapy; drug discovery; xenograft model.